Sparta Systems, Inc.
The cost of product quality issues and recalls can be irreversible – from plummeting revenue and share price to regulatory penalties and customer injury or loss of life.  Recent FDA initiated product recalls rose 69.5% from 2007 to 2012.  As a result, pharmaceutical companies must be vigilant about inspecting and auditing the quality of their own operations as well as throughout the value chain.
This eBook explains how an effective audit process enables manufacturing companies and its suppliers to raise performance levels and strengthen relationships while improving quality.